Targeting SIRT1 to inhibit the proliferation of multiple myeloma cells - PubMed
Source :
https://pubmed.ncbi.nlm.nih.gov/33732382/Multiple myeloma (MM) is the second most common hematopoietic malignancy and remains an incurable disease. Thus, novel drugs and therapeutic methods are required for patients with MM. The present study aimed to investigate the effect of sirtuin 1 (SIRT1) inhibitor cambinol on the proliferation and a ...